A long-term survivor with pulmonary large-cell neuroendocrine carcinoma

Respir Med. 2007 Nov;101(11):2425-7. doi: 10.1016/j.rmed.2006.06.034. Epub 2007 Aug 13.

Abstract

Pulmonary large-cell neuroendocrine carcinoma (LCNEC) has been characterized by highly aggressive behavior, with early spread to both regional lymph nodes and distant sites and a rapidly fatal course. In fact, no reports have described an advanced pulmonary LCNEC patient who has had long-term survival. A patient with large-sized pulmonary LCNEC, who is free of disease 11 years after surgery and postoperative chemotherapy, was reported.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Large Cell / diagnostic imaging
  • Carcinoma, Large Cell / therapy*
  • Carcinoma, Neuroendocrine / diagnostic imaging
  • Carcinoma, Neuroendocrine / therapy*
  • Combined Modality Therapy
  • Disease-Free Survival
  • Humans
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / therapy*
  • Male
  • Middle Aged
  • Radiography

Substances

  • Antineoplastic Agents